Race Oncology Ltd has released a press release.
Compelling Preclinical Breast Cancer Results
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Racura Oncology
- Race receives $387k R&D tax incentive refund
- Race AGM presentations and strategic update
- Impressive Preclinical Bisantrene Breast Cancer Results
- Prof Borje S Andersson appointed Chief Medical Officer
- Race leadership team strengthened
Later from Racura Oncology
- S&P DJI Announces March 2021 Quarterly Rebalance
- Race Initiates FTO Melanoma Preclinical Study
- Race Initiates FTO Directed Kidney Cancer Preclinical Study
- Race Initiates Extramedullary AML Preclinical Study
- Race Strategic Update March 2021
Follow Racura Oncology into a list and get an email when it puts out news.
Follow Racura Oncology